Author:
Herfert Kristina,Marciano Sabina,Kuebler Laura,Buss Sabrina,Landeck Natalie,Mannheim Julia G.,Napieczynska Hanna
Publisher
Springer International Publishing
Reference68 articles.
1. Zhang L, Villalobos A, Beck EM, Bocan T, Chappie TA, Chen L, et al. Design and selection parameters to accelerate the discovery of novel central nervous system positron emission tomography (PET) ligands and their application in the development of a novel phosphodiesterase 2A PET ligand. J Med Chem. 2013;56(11):4568–79.
2. Cheng Y, Prusoff WH. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol. 1973;22(23):3099–108.
3. Auld DS, Farmer MW, Kahl SD, Kriauciunas A, McKnight KL, Montrose C, et al. Receptor binding assays for HTS and drug discovery. In: Sittampalam GS, Coussens NP, Brimacombe K, editors. Assay guidance manual. Bethesda: Eli Lilly & Company and the National Center for Advancing Translational Sciences; 2012. p. 1–49.
4. Hulme EC, Trevethick MA. Ligand binding assays at equilibrium: validation and interpretation. Br J Pharmacol. 2010;161:1219–37.
5. Strome EM, Jivan S, Doudet DJ. Quantitative in vitro phosphor imaging using [3H] and [18F] radioligands: the effects of chronic desipramine treatment on serotonin 5-HT2 receptors. J Neurosci Methods. 2005;141(1):143–54.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献